Literature DB >> 21902581

Opportunistic and other infections in HIV-infected children in Latin America compared to a similar cohort in the United States.

Jorge O Alarcón1, Laura Freimanis-Hance, Margot Krauss, Mary F Reyes, Claudete Aparecida Araújo Cardoso, Marisa M Mussi-Pinhata, Edmundo Cardoso, Rohan Hazra.   

Abstract

Opportunistic and other infections have declined since the introduction of highly active antiretroviral therapy (HAART) in developed countries but few studies have addressed the impact of HAART in HIV-infected children from developing countries. This study examines the prevalence and incidence of opportunistic and other infections in Latin America during the HAART era. Vertically HIV-infected children enrolled in a cohort study between 2002 and 2007 were followed for the occurrence of 29 targeted infections. Cross-sectional and longitudinal analyses were performed to calculate the prevalence of infections before enrollment and the incidence rates of opportunistic and other infections after enrollment. Comparisons were made with data from a U.S. cohort (PACTG 219C). Of the 731 vertically HIV-infected children 568 (78%) had at least one opportunistic or other infection prior to enrollment. The most prevalent infections were bacterial pneumonia, oral candidiasis, varicella, tuberculosis, herpes zoster, and Pneumocystis jiroveci pneumonia. After enrollment, the overall incidence was 23.5 per 100 person-years; the most common infections (per 100 person-years) were bacterial pneumonia (7.8), varicella (3.0), dermatophyte infections (2.9), herpes simplex (2.5), and herpes zoster (1.8). All of these incidence rates were higher than those reported in PACTG 219C. The types and relative distribution of infections among HIV-infected children in Latin America in this study are similar to those seen in the United States but the incidence rates are higher. Further research is necessary to determine the reasons for these higher rates.

Entities:  

Mesh:

Year:  2011        PMID: 21902581      PMCID: PMC3292757          DOI: 10.1089/AID.2011.0057

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

1.  Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries.

Authors:  Rohan Hazra; Sonia K Stoszek; Laura Freimanis Hance; Jorge Pinto; Heloisa Marques; Mario Peixoto; Jorge Alarcon; Marisa Mussi-Pinhata; Leslie Serchuck
Journal:  Int J Epidemiol       Date:  2008-11-26       Impact factor: 7.196

2.  Evidence behind the WHO guidelines: hospital care for children: what is the aetiology of pneumonia in HIV-infected children in developing countries?

Authors:  Daniel Calder; Shamim Qazi
Journal:  J Trop Pediatr       Date:  2009-08       Impact factor: 1.165

3.  Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.

Authors:  S L Gortmaker; M Hughes; J Cervia; M Brady; G M Johnson; G R Seage; L Y Song; W M Dankner; J M Oleske
Journal:  N Engl J Med       Date:  2001-11-22       Impact factor: 91.245

4.  Impact of highly active antiretroviral therapy (HAART) on the incidence of opportunistic infections, hospitalizations and mortality among children and adolescents living with HIV/AIDS in Belo Horizonte, Minas Gerais State, Brazil.

Authors:  Talitah M S Candiani; Jorge Pinto; Claudete A Araújo Cardoso; Inácio R Carvalho; Arlete C M Dias; Mariângela Carneiro; Eugênio A Goulart
Journal:  Cad Saude Publica       Date:  2007       Impact factor: 1.632

5.  Causes of morbidity among HIV-infected children on antiretroviral therapy in primary care facilities in Lusaka, Zambia.

Authors:  Mwangelwa Mubiana-Mbewe; Carolyn Bolton-Moore; Yolan Banda; Namwinga Chintu; Mutinta Nalubamba-Phiri; Mark Giganti; M Brad Guffey; Pauline Sambo; Elizabeth M Stringer; Jeffrey S A Stringer; Benjamin H Chi
Journal:  Trop Med Int Health       Date:  2009-08-25       Impact factor: 2.622

6.  Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.

Authors:  Myron J Levin; Jeffrey P Anderson; George R Seage; Paige L Williams
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

7.  [HIV infection in Mexican children].

Authors:  G Martínez-Aguilar; R Vásquez-De Kartzow; M Nava-Frías; J I Santos-Preciado
Journal:  Salud Publica Mex       Date:  1995 Nov-Dec

8.  Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART.

Authors:  Elena Chiappini; Luisa Galli; Pier-Angelo Tovo; Clara Gabiano; Catiuscia Lisi; Guido Castelli Gattinara; Susanna Esposito; Alessandra Viganò; Carlo Giaquinto; Raffaella Rosso; Alfredo Guarino; Maurizio de Martino
Journal:  AIDS       Date:  2007-07-31       Impact factor: 4.177

9.  Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.

Authors:  Steven R Nesheim; Bill G Kapogiannis; Minn M Soe; Kevin M Sullivan; Elaine Abrams; John Farley; Paul Palumbo; Linda J Koenig; Marc Bulterys
Journal:  Pediatrics       Date:  2007-07       Impact factor: 7.124

10.  Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.

Authors:  Sarah M Wood; Samir S Shah; Andrew P Steenhoff; Richard M Rutstein
Journal:  Pediatrics       Date:  2007-12-17       Impact factor: 7.124

View more
  13 in total

1.  Impact of periodontal intervention on local inflammation, periodontitis, and HIV outcomes.

Authors:  J Valentine; T Saladyanant; K Ramsey; J Blake; T Morelli; J Southerland; E B Quinlivan; C Phillips; Jae Nelson; K DeParis; J Webster-Cyriaque
Journal:  Oral Dis       Date:  2016-04       Impact factor: 3.511

2.  Retroperitoneal aspergilloma.

Authors:  Selim R Butros; Millard L Tierce; Amy Marks; Chokechai Rongkavilit; Aparna Joshi
Journal:  Pediatr Radiol       Date:  2013-02-05

Review 3.  Understanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings.

Authors:  Surbhi Modi; Alex Chiu; Bernadette Ng'eno; Scott E Kellerman; Nandita Sugandhi; Lulu Muhe
Journal:  AIDS       Date:  2013-11       Impact factor: 4.177

4.  Morbidity and Mortality of a Cohort of Peruvian HIV-infected Children 2003-2012.

Authors:  Amira N Baker; Angela M Bayer; Rolando M Viani; Lenka Kolevic; Myung-Shin Sim; Jaime G Deville
Journal:  Pediatr Infect Dis J       Date:  2018-06       Impact factor: 3.806

5.  HIV-Care Outcome in Saudi Arabia; a Longitudinal Cohort.

Authors:  Maha A Al-Mozaini; Michael K Mansour; Abdullah A Al-Hokail; Magid A Mohmed; Munirah A Bin Daham; Hail M Al-Abdely; Husn H Frayha; Fahad A Al-Rabiah; Sami H Alhajjar; Salmaan Keshavjee; Chaker N Adra; Abdulrahman A Alrajhi
Journal:  J AIDS Clin Res       Date:  2014-11-08

Review 6.  The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis.

Authors:  P J Dodd; A J Prendergast; C Beecroft; B Kampmann; J A Seddon
Journal:  Thorax       Date:  2017-01-23       Impact factor: 9.139

Review 7.  The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.

Authors:  Annette H Sohn; Rohan Hazra
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

8.  Antiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional analysis.

Authors:  Barbara A Rath; Max von Kleist; Maria E Castillo; Lenka Kolevic; Patricia Caballero; Giselle Soto-Castellares; Angela M Amedee; James E Robinson; David K Katzenstein; Russell B Van Dyke; Richard A Oberhelman
Journal:  BMC Infect Dis       Date:  2013-01-02       Impact factor: 3.090

Review 9.  Pediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents.

Authors:  Adrienne G Randolph; Russell J McCulloh
Journal:  Virulence       Date:  2013-11-13       Impact factor: 5.882

10.  Incidence of tuberculosis in children on antiretroviral therapy: a retrospective cohort study.

Authors:  Aklilu Endalamaw; Eshetu Hailesilassie Engeda; Nega Tezera
Journal:  BMC Res Notes       Date:  2018-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.